DNA services/adaptive biotechnologies/LO
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700571P
- Awardee
-
Adaptive Biotechnologies Corporation UEI DMW5BNQ331K9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,750
Award facts
- Contract value 100% obligated
- $6,750.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Adaptive Biotechnologies Corporation for $6,750.00 on August 29, 2017, with completion scheduled for September 30, 2017. Performance is located in San Diego, California. The order covers DNA services using Adaptive's immunosequencing capabilities. This is a firm fixed-price acquisition with no set-aside designation.
Quick answers
Who was awarded contract HHSN261201700571P?
HHSN261201700571P was awarded to Adaptive Biotechnologies Corporation by National Cancer Institute (National Institutes of Health) on August 29, 2017.
How much is contract HHSN261201700571P worth?
The government has obligated $6,750 on HHSN261201700571P.
Was contract HHSN261201700571P competed?
The extent of competition for HHSN261201700571P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award